The article discusses ARK stocks and Cathie Wood's investment approach, focusing on disruptive innovation. It highlights CRISPR Therapeutics AG (NASDAQ:CRSP) and its potential in the gene sequencing industry. The stock ranks 3rd on the list of worst ARK stocks by short sellers.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing